| HOME >> BIOLOGY >> TECHNOLOGY |
Product sales - - 2,474,325
Total revenues 14,405,665 19,748,645 17,957,193
OPERATING EXPENSES:
Cost of product sales - 2,041,175 534,932
Royalties - 299,995 328,401
Research and development 36,913,739 41,013,894 25,045,279
General and administrative 7,293,091 6,843,817 7,460,607
Total operating expenses 44,206,830 50,198,881 33,369,219
Loss from operations (29,801,165) (30,450,236) (15,412,026)
OTHER INCOME (EXPENSE):
Investment income 1,324,671 855,601 488,262
Interest expense (53,339) (30,522) (14,487)
Total other income, net 1,271,332 825,079 473,775
Loss before income taxes (28,529,833) (29,625,157) (14,938,251)
Income tax benefit 778,308 666,275 580,275
NET LOSS $(27,751,525) $(28,958,882) $(14,357,976)
Basic and diluted net loss
per common share $(0.36) $(0.48) $(0.27)
Weighted average number of
common shares outstanding
used in computing basic and
diluted net loss per common
share 76,204,160 60,356,610 53,861,182
PALATIN TECHNOLOGIES, INC.
Consolidated Balance Sheet Data
June 30, 2007 June 30, 2006
ASSETS
Current assets:
Cash and cash equivalents $31,447,615 $28,333,211
Available-for-sale investments 2,323,642 2,330,834
Accounts receivable 607,841 69,591
<| SOURCE Palatin Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |